HDAC9 and diabetes mellitus: In the setting of diabetes, recent evidence indicates that HDAC inhibition increases the levels of antioxidant enzymes and reduces cardiac dysfunction in experimental models of advanced type I diabetes [16] and ameliorates cardiac performance and metabolic disturbances in murine models of both type I and type II diabetes [2,17].